Search

Your search keyword '"Mastroianni C."' showing total 916 results

Search Constraints

Start Over You searched for: Author "Mastroianni C." Remove constraint Author: "Mastroianni C."
916 results on '"Mastroianni C."'

Search Results

1. Memory-Augmented Hybrid Quantum Reservoir Computing

2. A hybrid classical-quantum approach to speed-up Q-learning

6. Management of intra-abdominal infections: recommendations by the Italian council for the optimization of antimicrobial use

9. In-label, off-label prescription, efficacy and tolerability of dalbavancin: report from a National Registry

10. Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration

11. Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort

15. Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies

16. Luminescent Polymeric Nanovectors Loaded with Darunavir for Treatment of HIV-Associated Neurological Diseases

18. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy

19. The effect of switching to Maraviroc + Darunavir/ritonavir dual therapy in virologically suppressed patients on the progression of liver fibrosis: findings from a randomized study

20. Epidemiology, aetiology and treatment of skin and soft tissue infections: final report of a prospective multicentre national registry

21. HDV epidemic in Central Italy is stable over the last two decades and is characterized by the circulation of multiple HDV sub-genotypes 1 inducing different inflammatory stimuli

22. A hybrid classical-quantum approach to speed-up Q-learning

23. Pillars of long-term antiretroviral therapy success

24. Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study

25. Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL

26. Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000–14

28. Resistance analysis and treatment outcomes in hepatitis C virus genotype 3-infected patients within the Italian network VIRONET-C

29. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study

31. Efficacy and durability of two‐ vs . three‐drug integrase inhibitor‐based regimens in virologically suppressed HIV‐infected patients: Data from real‐life ODOACRE cohort

32. Factors influencing place of death and disenrollment among patients receiving specialist palliative care

33. COVID-19 and kidney: role of SARS-CoV-2 infection in the induction of renal damage.

34. Resistance analysis and treatment outcomes in hepatitis C virus genotype 3-infected patients within the Italian network VIRONET-C

35. Male reproductive health after 3 months from SARS-CoV-2 infection: a multicentric study

36. HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels

37. Clinical management of imported malaria in Italy: Results from a national cross-sectional survey in 2015

38. Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

39. Latent tuberculosis infection screening in persons newly-diagnosed with HIV infection in Italy: A multicentre study promoted by the Italian Society of Infectious and Tropical Diseases

40. Covid-19 and the role of smoking: The protocol of the multicentric prospective study COSMO-IT (covid19 and smoking in italy)

41. Von Willebrand factor with increased binding capacity is associated with reduced platelet aggregation but enhanced agglutination in COVID-19 patients: another COVID-19 paradox?

42. Anti-HIV Drugs Decrease the Expression of Matrix Metalloproteinases in Astrocytes and Microglia

43. The neutrophil/lymphocyte ratio as a prognostic factor in COVID-19 patients: a case-control study

44. CD4/CD8 ratio in pregnant women with HIV and its association with pregnancy outcome: data from a national study in Italy

45. Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9)

48. Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL

49. Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?

50. HepaDisk – A new quality of life questionnaire for HCV patients

Catalog

Books, media, physical & digital resources